N -(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis

This publication has 33 references indexed in Scilit:

• Amyloid β2-microglobulin is modified with Nε-(carboxymethyl)lysine in dialysis-related amyloidosis
  Kidney International, 1996
• Role of the Maillard Reaction in Diabetes Mellitus and Diseases of Aging
  Drugs & Aging, 1996
• Advanced oxidation protein products as a novel marker of oxidative stress in uremia
  Kidney International, 1996
• The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions
  Journal of Biological Chemistry, 1996
• Role of polyol pathway in nonenzymatic glycation
  Nephrology Dialysis Transplantation, 1996
• N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins
  Biochemistry, 1995
• Elevated Serum Levels of 3-Deoxyglucosone, a Potent Protein-Cross-Linking Intermediate of the Maillard Reaction, in Uremic Patients
  Nephron, 1995
• Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis or CAPD
  Kidney International, 1994
• Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
  New England Journal of Medicine, 1988
• A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin
  Biochemical and Biophysical Research Communications, 1985